Smart watch‑based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease
| العنوان: | Smart watch‑based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease |
|---|---|
| المؤلفون: | Osamu Taguchi, Tadashi Sakaguchi, Tetsu Kobayashi, Corina D'Alessandro Gabazza, Haruko Saiki, Kentaro Ito, Osamu Hataji, Esteban C. Gabazza, Hajime Fujimoto, Yuta Suzuki, Yoichi Nishii |
| المصدر: | Experimental and Therapeutic Medicine |
| بيانات النشر: | Spandidos Publications, 2017. |
| سنة النشر: | 2017 |
| مصطلحات موضوعية: | Cancer Research, medicine.medical_specialty, Randomization, Combination therapy, physical activity, Placebo, chronic obstructive pulmonary disease, Pulmonary function testing, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Immunology and Microbiology (miscellaneous), Quality of life, long-acting muscarinic antagonist, Medicine, 030212 general & internal medicine, long-acting β2-agonist, smart watch, COPD, business.industry, Olodaterol, Articles, General Medicine, medicine.disease, humanities, respiratory tract diseases, Clinical trial, 030228 respiratory system, chemistry, Physical therapy, business, human activities |
| الوصف: | Combined therapy with tiotropium and olodaterol notably improves parameters of lung function and quality of life in patients with chronic obstructive pulmonary disease (COPD) compared to mono-components; however, its effect on physical activity is unknown. The present study evaluated whether combination therapy affects daily physical performance in patients with COPD under a smart watch-based encouragement program. This was a non-blinded clinical trial with no randomization or placebo control. A total of 20 patients with COPD were enrolled in the present study. The patients carried an accelerometer for 4 weeks; they received no therapy during the first 2 weeks but they were treated with combined tiotropium and olodaterol under a smart watch-based encouragement program for the last 2 weeks. The pulmonary function test, COPD assessment test, 6-min walk distance and parameters of physical activity were significantly improved (P |
| تدمد: | 1792-1015 1792-0981 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd49938596ff8b0c83b62421514b8e9eTest https://doi.org/10.3892/etm.2017.5088Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....bd49938596ff8b0c83b62421514b8e9e |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 17921015 17920981 |
|---|